Causes and consequences of hyperglycemia in critical illness

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 4, 2007, Pages 498-503

  Falciglia, Mercedes ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Critical illness; Glucose intolerance; Hyperglycemia; Stress

Indexed keywords

GLUCOSE; INSULIN;

CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; REVIEW; STRESS;

BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; STRESS; TREATMENT OUTCOME;

EID: 34250653598     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3281a3bf0a     Document Type: Review

References (74)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27:553-597.
3. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006; 355:1903-1911.
4. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003; 88:2430-2437.
5. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement oninpatient diabetes and glycemic control: a call to action. Diabetes Care 2006; 29:1955-1962.
6. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355:773-778.
7. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426-2432.
8. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146:30-34.
9. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-1021.
10. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146:233-243. This randomized trial of tight glycemic control during cardiac surgery found no difference between groups in a composite clinical end-point. All patients received tight control postoperatively, and so this study raises the question of how much time is necessary to observe a benefit from glycemic control.
11. Kernan WN, Viscoli CM, Inzucchi SE, et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 2005; 165:227-233.
12. Levetan CS, Passaro M, Jablonski K, et al. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998; 21:246-249.
13. Gray CS, Scott JF, French JM, et al. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004; 33:71-77.
14. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632.
15. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140-2144.
16. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22:1827-1831.
17. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982.
18. Cely CM, Arora P, Quartin AA, et al. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004; 126:879-887.
19. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461. This is the first randomized controlled trial to showthat normalization of blood glucose in a medical ICU results in decreased morbidity and mortality. The finding that mortality reduction was observed in patients staying longer than 3 days suggests that the benefits from intensive insulin therapy may require time to manifest.
20. Bauters C, Ennezat PV, Tricot O, et al. Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in nondiabetic patients. Eur Heart J 2007; 28:546-552.
21. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 2005; 22:1321-1325.
22. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27:1289-1297. Suggesting the importance of prompt correction of hyperglycemia, this study showed that not only elevated baseline glucose but also the failure of glucose levels to decrease during the first 24 h after acute myocarial infarction predicted higher mortality in nondiabetic patients.
23. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004; 21:305-310.
24. Ishihara M, Kojima S, Sakamoto T, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150:814-820.
25. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111:754-760.
26. Timmer JR, Ottervanger JP, Bilo HJ, et al. Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM 2006; 99:237-243.
27. Timmer JR, van der Horst IC, Ottervanger JP, et al. Prognostic value of admission glucose in nondiabetic patients with myocardial infarction. Am Heart J 2004; 148:399-404.
28. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40:1748-1754.
29. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111:3078-3086.
30. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-674.
31. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047.
32. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478.
33. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-360; discussion 360-362.
34. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22:1408-1414.
35. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56:1058-1062.
36. Vogelzang M, Nijboer JM, van der Horst IC, et al. Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 2006; 60:873-877; discussion 878-879. This study demonstrated that the association between hyperglycemia andmortality in a surgical ICU was most pronounced in patients suffering trauma, highlighting the need for a trial in trauma patients and that risk from hyperglycemia may be variable.
37. Sung J, Bochicchio GV, Joshi M, et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80-83.
38. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58:921-924.
39. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353.
40. McGirt MJ, Woodworth GF, Brooke BS, et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006; 58 (6):1066-1073; discussion 1066-1073.
41. Newton JD, Squire IB. Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure. Heart 2006; 92:1441-1446.
42. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006; 166:1613-1619.
43. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61:284-289.
44. Kao LS, Morris BH, Lally KP, et al. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006; 26:730-736. This study demonstrated that hyperglycemia increased the risk for mortality and sepsis in extremely low birth weight infants, a population with unique defects in glucose regulation.
45. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151-3159. This pooled analysis of previously published randomized trial data from surgical and medical ICUs demonstrates that normalization of blood glucose decreases morbidity and mortality. Although intensive insulin therapy is most effective after 3 days, it appears safe to initiate this treatment during the early days of hospitalization.
46. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2006; 30:164-172. This meta-analysis of insulin therapy in ICU patients demonstrates that insulin treatment resulted in decreased mortality in trials where glucose control was a goal, andwhen glucose-insulin-potassiumpreparations were not the method of infusion.
47. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366.
48. Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29:765-770.
49. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446.
50. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.
51. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000.
52. Anonymous. Glucontrol Study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. http://clinicaltrials.gov/ ct/gui/show/NCT00107601?order=1. [Accessed 17 February 2007].
53. Ligtenberg JJ, Meijering S, Stienstra Y, et al. Mean glucose level is not an independent risk factor for mortality in mixed ICU patients. Intensive Care Med 2006; 32:435-438.
54. Whitcomb BW, Pradhan EK, Pittas AG, et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005; 33:2772-2777.
55. Yang SY, Zhang S, Wang ML. Clinical significance of admission hyperglycemia and factors related to it in patients with acute severe head injury. Surg Neurol 1995; 44:373-377.
56. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in nondiabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986; 293:917-922.
57. Tenerz A, Nilsson G, Forberg R, et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in nondiabetic patients. J Intern Med 2003; 254:494-503.
58. van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ. Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 1993; 24:1129-1132.
59. Heath DF. Glucose, insulin and other plasma metabolites shortly after injury. J Accid Emerg Med 1994; 11:67-77.
60. Sam S, Corbridge TC, Mokhlesi B, et al. Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 2004; 60:29-35.
61. US Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2003.
62. Cheung NW, Helmink D. Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. J Diabetes Complications 2006; 20:21-25.
63. Albareda M, Caballero A, Badell G, et al. Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism 2005; 54:1115-1121.
64. Kahn SE. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86:4047-4058.
65. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672.
66. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-361.
67. Yudkin JS, Oswald GA, McKeigue PM, et al. The relationship of hospital admission and fatality from myocardial infarction to glycohaemoglobin levels. Diabetologia 1988; 31:201-205.
68. Husband DJ, Alberti KG, Julian DG. "Stress" hyperglycaemia during acute myocardial infarction: an indicator of preexisting diabetes? Lancet 1983; 2:179-181.
69. Ishihara M, Inoue I, Kawagoe T, et al. Is admission hyperglycaemia in nondiabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 2006; 27:2413-2419. The finding that admission glucose in patients suffering acute myocardial infarction was not predictive of future glucose intolerance after discharge illustrates that the etiology of hyperglycemia in critically ill patients remains unclear.
70. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med 1987; 4:68-70.
71. Choi KM, Lee KW, Kim SG, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90:175-180.
72. Vancheri F, Curcio M, Burgio A, et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM 2005; 98:871-878.
73. Wallander M, Bartnik M, Efendic S, et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 2005; 48:2229-2235.
74. Hashimoto K, Ikewaki K, Yagi H, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005; 28:1182-1186.